Health Care Technology
Company Overview of iRhythm Technologies, Inc.
iRhythm Technologies, Inc., a digital healthcare company, develops and commercializes FDA-cleared solutions that integrate biosensor technology, patient data, analytics, and medical expertise for institutions and patients in the United States and internationally. It offers ZIO Service, which provides a proven approach to long-term continuous monitoring that enables diagnosis earlier in the clinical pathway to improve patient outcomes and reduce healthcare costs. The company was founded in 2006 and is headquartered in San Francisco, California with locations in Lincolnshire, Illinois; Houston, Texas; and Huntington Beach, California.
650 Townsend Street
San Francisco, CA 94103
Founded in 2006
Key Executives for iRhythm Technologies, Inc.
Chief Executive Officer, President and Director
Chief Clinical Officer and Executive Vice President
Executive Vice President of Corporate Sales & Payer Relations
Executive Vice President of Strategy and Corporate Development
Compensation as of Fiscal Year 2015.
iRhythm Technologies, Inc. Key Developments
iRhythm Technologies, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 01:00 PM
Oct 31 15
iRhythm Technologies, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 01:00 PM. Venue: Westin Grand Central, New York, New York, United States.
iRhythm Technologies, Inc. Presents at MEDevice San Diego Conference & Showcase, Sep-02-2015 03:45 PM
Jul 30 15
iRhythm Technologies, Inc. Presents at MEDevice San Diego Conference & Showcase, Sep-02-2015 03:45 PM. Venue: San Diego Marriott Marquis & Marina, San Diego, California, United States. Speakers: Kevin M. King, Chief Executive Officer, President and Director.
iRhythm Technologies Appoints Marga Ortigas-Wedekind as Executive Vice President, Global Marketing
Jul 21 15
iRhythm Technologies, Inc. announced that Marga Ortigas-Wedekind, an experienced healthcare and medical device marketing and product development leader, has joined the company's senior management as executive vice president, global marketing. In this role, Ortigas-Wedekind will be responsible for developing and executing the marketing strategy for iRhythm's ZIO® Service, which combines wearable biosensor devices with mobile and cloud-based technology to improve the diagnosis and treatment of arrhythmias. Under Ortigas-Wedekind's leadership, iRhythm will develop a global brand architecture to accelerate widespread awareness for the ZIO® Service and its benefits. She will also work with payers to develop comprehensive reimbursement strategies to support iRhythm in launching new products and entering new markets. Prior to joining iRhythm, Ortigas-Wedekind was executive vice president, global marketing and product development for Omnicell Inc.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|